FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eric Nuermberger

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Anatomy

Lung

Concepts & Ideas

Physiology

Bacterial Drug Resistance

Co-author Network

Publications

TOP 3
Kelly E Dooley; Nadza Durakovic; Carole D Mitnick; Eric Nuermberger; Ekwaro A Obuku; Vera Belitsky
World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?
Deepak V Almeida; Paul J Converse; Si-Yang Li; Eric Nuermberger; Sandeep Tyagi; Jacques H Grosset
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.
Eric Nuermberger; Charles A Peloquin; Ian M Rosenthal; Rokeya Tasneen; Petros C Karakousis; Khisimuzi E Mdluli; Jacques H Grosset
Reply to "Contradictory results with high-dosage rifamycin in mice and humans".

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eric Nuermberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kelly E Dooley; Nadza Durakovic; Carole D Mitnick; Eric Nuermberger; Ekwaro A Obuku; Vera Belitsky
World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?
The Journal of infectious diseases 2013;207(9):1352-8.
2013: Deepak V Almeida; Paul J Converse; Si-Yang Li; Eric Nuermberger; Sandeep Tyagi; Jacques H Grosset
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.
PLoS neglected tropical diseases 2013;7(2):e2085.
2013: Eric Nuermberger; Charles A Peloquin; Ian M Rosenthal; Rokeya Tasneen; Petros C Karakousis; Khisimuzi E Mdluli; Jacques H Grosset
Reply to "Contradictory results with high-dosage rifamycin in mice and humans".
Antimicrobial agents and chemotherapy 2013;57(2):1104-5.
2013: Kelly E Dooley; Nadza Durakovic; Carol D Hamilton; Mamodikoe Makhene; Carole D Mitnick; Eric Nuermberger; Ekwaro Obuku; Sarita Shah; James C M Brust; Mary Ann Degroote
Reply to Seddon, Schaaf, and Hesseling.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(1):168-9.
2012: Zahoor Ahmad; Deepak Almeida; Anthony S Baughn; Williams R Jacobs; Austin Minkowsk; Eric Nuermberger; Kaitlin M Peck; Sandeep Tyagi; John T Welch; Jacques H Grosset
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
The Indian journal of medical research 2012;136(5):808-14.
2012: Scott G Franzblau; Khisimuzi Mdluli; Eric Nuermberger; Ian M Orme; Koen Andries; Iñigo Angulo-Barturen; Sang Hyun Cho; Veronique Dartois; Mary Ann DeGroote; Thomas Dick; Anne J Lenaerts
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.
Tuberculosis (Edinburgh, Scotland) 2012;92(6):453-88.
2012: Ben Gold; Xiuju Jiang; W Clay Bracken; Steven J Brickner; Tamutenda Chidawanyika; Amy Cunningham-Bussel; Crystal Darby; Haiteng Deng; Joseph Fernandez; J Fraser Glickman; Eric Nuermberger; Ouathek Ouerfelli; Maneesh R Pingle; Poonam Rath; Ronald Realubit; Julia Roberts; Mark Rundell; Nilesh Shah; Selin Somersan; Aditya Venugopal; J David Warren; Thulasi Warrier; Carl F Nathan
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(40):16004-11.
2012: Susan E Dorman; Pei-Jean Feng; Stefan Goldberg; Betial Haile; Charles M Heilig; John L Johnson; Ruth Moro; Grace Muzanyi; Payam Nahid; Masahiro Narita; Eric Nuermberger; Susan Ray; Neil W Schluger; Jason Stout; Andrew Vernon; Marc Weiner; Edward Bates; Lorna Bozeman
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
The Journal of infectious diseases 2012;206(7):1030-40.
2012: Ian M Rosenthal; Rokeya Tasneen; Ming Zhang; Charles A Peloquin; Deepak Almeida; Jacques H Grosset; Petros C Karakousis; Khisimuzi E Mdluli; Eric Nuermberger
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Antimicrobial agents and chemotherapy 2012;56(8):4331-40.
2012: Kelly E Dooley; Nadza Durakovic; Carol D Hamilton; Mamodikoe Makhene; Carole D Mitnick; Eric Nuermberger; Ekwaro Obuku; Sarita Shah; Mary Ann DeGroote; Vera Belitsky; James C M Brust
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(4):572-81.
2012: Noton Kumar Dutta; Jacques H Grosset; PETER ILLEI; Khisimuzi E Mdluli; Eric Nuermberger; Charles A Peloquin; Michael L Pinn; Petros C Karakousis
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Antimicrobial agents and chemotherapy 2012;56(7):3726-31.
2012: Richard E Chaisson; Eric Nuermberger
Confronting multidrug-resistant tuberculosis.
The New England journal of medicine 2012;366(23):2223-4.
2012: K-C Chang; Eric Nuermberger
2011: the year in review. part I: tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012;16(6):740-8.
2012: Kathy Williams; Charles A Peloquin; Dinesh Taylor; Robert S Wallis; Opokua Amoabeng; Koen Andries; Khisimuzi E Mdluli; Austin Minkowski; Eric Nuermberger
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2012;56(6):3114-20.
2012: K E Dooley; E E Bliven-Sizemore; W J Burman; Edward J Fuchs; Walter Hubbard; Y Lu; Michael THOMAS Melia; Eric Nuermberger; M Weiner; Susan E Dorman
Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.
Clinical pharmacology and therapeutics 2012;91(5):881-8.
2012: Jamie Harper; William R Bishai; Stephanie L Davis; Igor Kramnik; Eric Nuermberger; Martin G Pomper; Ciaran Skerry; Rokeya Tasneen; Mariah Weir; Sanjay K Jain
Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.
The Journal of infectious diseases 2012;205(4):595-602.
2012: Tianyu Zhang; Si-Yang Li; Eric Nuermberger
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy.
PloS one 2012;7(1):e29774.
2011: Rokeya Tasneen; Dinesh Taylor; Kathy N Williams; Charles A Peloquin; Koen Andries; Si-Yang Li; Khisimuzi E Mdluli; Eric Nuermberger
Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(12):5485-92.
2011: Paul J Converse; Deepak V Almeida; Eric Nuermberger; Jacques H Grosset
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
Future microbiology 2011;6(10):1185-98.
2011: Tianyu Zhang; Kathy N Williams; Si-Yang Li; Koen Andries; Eric Nuermberger
Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection.
American journal of respiratory and critical care medicine 2011;184(6):732-7.
2011: Zahoor Ahmad; Mostafa M Fraig; Jacques H Grosset; Eric Nuermberger; Michael L Pinn; Sandeep Tyagi; Petros C Karakousis
Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
The Journal of antimicrobial chemotherapy 2011;66(7):1560-6.
2011: Ming Zhang; Si-Yang Li; Ian M Rosenthal; Deepak V Almeida; Zahoor Ahmad; Paul J Converse; Charles A Peloquin; Eric Nuermberger; Jacques H Grosset
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
American journal of respiratory and critical care medicine 2011;183(9):1254-61.
2011: Zahoor Ahmad; Mostafa M Fraig; Gregory P Bisson; Eric Nuermberger; Jacques H Grosset; Petros C Karakousis
Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
Antimicrobial agents and chemotherapy 2011;55(4):1527-32.
2011: Zahoor Ahmad; Austin Minkowski; Charles A Peloquin; Kathy N Williams; Khisimuzi E Mdluli; Jacques H Grosset; Eric Nuermberger
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(4):1781-3.
2011: Paul J Converse; Deepak V Almeida; Eric Nuermberger; Jacques H Grosset
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
PLoS neglected tropical diseases 2011;5(3):e985.
2011: Deepak Almeida; Paul J Converse; Zahoor Ahmad; Kelly E Dooley; Eric Nuermberger; Jacques H Grosset
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
PLoS neglected tropical diseases 2011;5(1):e933.
2011: Tianyu Zhang; Si-Yang Li; Paul J Converse; Deepak V Almeida; Jacques H Grosset; Eric Nuermberger
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.
Antimicrobial agents and chemotherapy 2011;55(1):56-61.
2011: Zahoor Ahmad; Charles A Peloquin; Rajendra P Singh; Hartmut Derendorf; Sandeep Tyagi; Ann Ginsberg; Jacques H Grosset; Eric Nuermberger
PA-824 exhibits time-dependent activity in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(1):239-45.
2010: Zahoor Ahmad; Michael L Pinn; Eric Nuermberger; Charles A Peloquin; Jacques H Grosset; Petros C Karakousis
The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.
The Journal of antimicrobial chemotherapy 2010;65(10):2172-5.
2010: Eric Nuermberger; Melvin K Spigelman; Wing Wai Yew
Current development and future prospects in chemotherapy of tuberculosis.
Respirology (Carlton, Vic.) 2010;15(5):764-78.
2010: Tianyu Zhang; William R Bishai; Jacques H Grosset; Eric Nuermberger
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Antimicrobial agents and chemotherapy 2010;54(7):2806-13.
2010: Zahoor Ahmad; Eric Nuermberger; Rokeya Tasneen; Michael L Pinn; Kathy N Williams; Charles A Peloquin; Jacques H Grosset; Petros C Karakousis
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
The Journal of antimicrobial chemotherapy 2010;65(4):729-34.
2010: Paul J Converse; Kathleen D Eisenach; Sue A Theus; Eric Nuermberger; Sandeep Tyagi; Lan H Ly; Deborah E Geiman; Haidan Guo; Scott Nolan; Nicole C Akar; Lee G Klinkenberg; Radhika Gupta; Shichun Lun; Petros C Karakousis; Gyanu Lamichhane; David N McMurray; Jacques H Grosset; William R Bishai
The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models.
PloS one 2010;5(4):e10289.
2009: Tianyu Zhang; Ming Zhang; Ian M Rosenthal; Jacques H Grosset; Eric Nuermberger
Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.
American journal of respiratory and critical care medicine 2009;180(11):1151-7.
2009: Stephanie L Davis; Eric Nuermberger; Peter K Um; Camille Vidal; Bruno Jedynak; Martin G Pomper; William R Bishai; Sanjay K Jain
Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.
Antimicrobial agents and chemotherapy 2009;53(11):4879-84.
2009: Zahoor Ahmad; Lee G Klinkenberg; Michael L Pinn; Mostafa M Fraig; Charles A Peloquin; William R Bishai; Eric Nuermberger; Jacques H Grosset; Petros C Karakousis
Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
The Journal of infectious diseases 2009;200(7):1136-43.
2009: Deepak Almeida; Eric Nuermberger; Rokeya Tasneen; Ian Rosenthal; Sandeep Tyagi; Kathy Williams; Charles Peloquin; Jacques H Grosset
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
Antimicrobial agents and chemotherapy 2009;53(10):4178-84.
2009: Kathy N Williams; Steven J Brickner; C Kendall Stover; Tong Zhu; Adam Ogden; Rokeya Tasneen; Sandeep Tyagi; Jacques H Grosset; Eric Nuermberger
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
American journal of respiratory and critical care medicine 2009;180(4):371-6.
2009: Susan E Dorman; John L Johnson; Stefan Goldberg; Grace Muzanye; Nesri Padayatchi; Lorna Bozeman; Charles M Heilig; John Bernardo; Shurjeel Choudhri; Jacques H Grosset; Elizabeth Guy; Priya Guyadeen; Maria Corazon Leus; Gina Maltas; Dick Menzies; Eric Nuermberger; Margarita Villarino; Andrew Vernon; Richard E Chaisson
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
American journal of respiratory and critical care medicine 2009;180(3):273-80.
2009: Kathy N Williams; C Kendall Stover; T Zhu; R Tasneen; Sandeep Tyagi; Jacques H Grosset; Eric Nuermberger
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Antimicrobial agents and chemotherapy 2009;53(4):1314-9.
2009: Paul J Converse; Petros C Karakousis; Lee G Klinkenberg; Anup Kesavan; Lan H Ly; Shannon Sedberry Allen; Jacques H Grosset; Sanjay K Jain; Gyanu Lamichhane; Yukari C Manabe; David N McMurray; Eric Nuermberger; William R Bishai
Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.
Infection and immunity 2009;77(3):1230-7.
2009: Eric Nuermberger; Denis A Mitchison
Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.
American journal of respiratory and critical care medicine 2009;179(1):2-3.
2008: Kelly Dooley; Charles Flexner; Judith Hackman; Charles A Peloquin; Eric Nuermberger; Richard E Chaisson; Susan E Dorman
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
Antimicrobial agents and chemotherapy 2008;52(11):4037-42.
2008: Ian M Rosenthal; Ming Zhang; Deepak Almeida; Jacques H Grosset; Eric Nuermberger
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
American journal of respiratory and critical care medicine 2008;178(9):989-93.
2008: Eric Nuermberger
Using animal models to develop new treatments for tuberculosis.
Seminars in respiratory and critical care medicine 2008;29(5):542-51.
2008: Rokeya Tasneen; Sandeep Tyagi; Kathy Williams; Jacques H Grosset; Eric Nuermberger
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(10):3664-8.
2008: Geraint R Davies; Eric Nuermberger
Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs.
Tuberculosis (Edinburgh, Scotland) 2008;88 Suppl 1():S65-74.
2008: ARUNA SUBRAMANIAN; Eric Nuermberger
Tuberculosis in transplant recipients: diagnostic and therapeutic dilemmas.
Transplant infectious disease : an official journal of the Transplantation Society 2008;10(4):229-30.
2008: Eric Nuermberger
Older antibiotic gains new respect as potent treatment for tuberculosis. Rifapentine is already approved for use with humans.
Home healthcare nurse 2008;26(4):204-5.
2008: Eric Nuermberger; Sandeep Tyagi; Rokeya Tasneen; Kathy N Williams; Deepak Almeida; Ian M Rosenthal; Jacques H Grosset
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(4):1522-4.
2007: Ian M Rosenthal; Ming Zhang; Kathy N Williams; Charles A Peloquin; Sandeep Tyagi; Andrew Vernon; William R Bishai; Richard E Chaisson; Jacques H Grosset; Eric Nuermberger
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
PLoS medicine 2007;4(12):e344.
2007: Deepak Almeida; Eric Nuermberger; Sandeep Tyagi; William R Bishai; Jacques H Grosset
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2007;51(12):4261-6.
2007: Annick Chauty; Marie-Françoise Ardant; Ambroise Adeye; Hélène Euverte; Augustin Guédénon; Christian Johnson; Jacques Aubry; Eric Nuermberger; Jacques H Grosset
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Antimicrobial agents and chemotherapy 2007;51(11):4029-35.
2007: Sean T Byrne; Steven M Denkin; Peihua Gu; Eric Nuermberger; Ying Zhang
Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
Journal of medical microbiology 2007;56(Pt 8):1047-51.
2007: Sanjay K Jain; S Moises Hernandez-Abanto; Qi-Jian Cheng; Prabhpreet Singh; Lan H Ly; Lee G Klinkenberg; Norman E Morrison; Paul J Converse; Eric Nuermberger; Jacques H Grosset; David N McMurray; Petros C Karakousis; Gyanu Lamichhane; William R Bishai
Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice.
The Journal of infectious diseases 2007;195(11):1634-42.
2007: Geraint R Davies; A S Pym; Denis A Mitchison; Eric Nuermberger; Jacques H Grosset
Evaluation of new antituberculosis drugs in mouse models.
Antimicrobial agents and chemotherapy 2007;51(1):403; author reply 403-4.
2006: Eric Nuermberger; Ian M Rosenthal; Sandeep Tyagi; Kathy N Williams; Deepak Almeida; Charles A Peloquin; William R Bishai; Jacques H Grosset
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2006;50(8):2621-5.
2006: Ian M Rosenthal; Kathy Williams; Sandeep Tyagi; Charles A Peloquin; Andrew Vernon; William R Bishai; Jacques H Grosset; Eric Nuermberger
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
American journal of respiratory and critical care medicine 2006;174(1):94-101.
2005: Eric Nuermberger
Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.
Pharmacotherapy 2005;25(12 Pt 2):134S-139S.
2005: Eric Nuermberger; Kristi L. Helke; William R Bishai
Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy.
International journal of antimicrobial agents 2005;26(6):497-503.
2005: Eric Nuermberger; Sandeep Tyagi; Kathy N Williams; Ian M Rosenthal; William R Bishai; Jacques H Grosset
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
American journal of respiratory and critical care medicine 2005;172(11):1452-6.
2005: Ian M Rosenthal; Kathy Williams; Sandeep Tyagi; Andrew Vernon; Charles A Peloquin; William R Bishai; Jacques H Grosset; Eric Nuermberger
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.
American journal of respiratory and critical care medicine 2005;172(11):1457-62.
2005: Sandeep Tyagi; Eric Nuermberger; Tetsuyuki Yoshimatsu; Kathy Williams; Ian M Rosenthal; Nacer Lounis; William R Bishai; Jacques H Grosset
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2005;49(6):2289-93.
2005: Nicola Zetola; John S Francis; Eric Nuermberger; William R Bishai
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.
The Lancet infectious diseases 2005;5(5):275-86.
2005: John S Francis; Meg C Doherty; Uri Lopatin; Cecilia P Johnston; GITA SINHA; Tracy Ross; Mian Cai; Nadia N Hansel; Trish M Perl; John Ticehurst; Karen C Carroll; David L Thomas; Eric Nuermberger; John G Bartlett
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(1):100-7.
2004: Eric Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; Kathy Williams; Ian M Rosenthal; Richard J O'Brien; Andrew Vernon; Richard E Chaisson; William R Bishai; Jacques H Grosset
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;170(10):1131-4.
2004: Petros C Karakousis; Tetsuyuki Yoshimatsu; Gyanu Lamichhane; Samuel C Woolwine; Eric Nuermberger; Jacques H Grosset; William R Bishai
Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.
The Journal of experimental medicine 2004;200(5):647-57.
2004: Eric Nuermberger; William R Bishai; Jacques H Grosset
Latent tuberculosis infection.
Seminars in respiratory and critical care medicine 2004;25(3):317-36.
2004: Eric Nuermberger; William R Bishai
Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38 Suppl 4():S363-71.
2004: Eric Nuermberger; Jacques H Grosset
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(4):243-55.
2004: Eric Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; William R Bishai; Jacques H Grosset
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.
Infection and immunity 2004;72(2):1065-71.
2004: Eric Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; Richard J O'Brien; Andrew N Vernon; Richard E Chaisson; William R Bishai; Jacques H Grosset
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;169(3):421-6.
2004: Eric Nuermberger; William R Bishai
The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(1):99-103.
2003: Eric Nuermberger; William R Bishai
Significance of macrolide resistance in Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 2003;52(3):524-5; author reply 525.
2002: Sophie Lanzkron; Alison R Moliterno; Edward J Norris; Steven A Gould; Jodi Segal; Eric Nuermberger; Paul M Ness
Polymerized human Hb use in acute chest syndrome: a case report.
Transfusion 2002;42(11):1422-7.
2002: Tetsuyuki Yoshimatsu; Eric Nuermberger; Sandeep Tyagi; Richard E Chaisson; William R Bishai; Jacques H Grosset
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.
Antimicrobial agents and chemotherapy 2002;46(6):1875-9.
2002: Jennifer S Myers; Eric Nuermberger
Cases from the Osler Medical Service at Johns Hopkins University. Diagnosis: Polymorphic population of mature and immature hematopoietic cells consistent with extramedullary hematopoiesis.
The American journal of medicine 2002;112(6):494-5.
2002: Eric Nuermberger
Cases from the Osler medical service at Johns Hopkins university.
The American journal of medicine 2002;112(1):70-1.
2000: Joseph A Eustace; Eric Nuermberger; Michael J Choi; Paul J Scheel; Richard D Moore; William A Briggs
Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids.
Kidney international 2000;58(3):1253-60.